🦴 Basic Structure and Function of Bone: A Study Guide

Source Information: This study material has been compiled from copy-pasted text and a lecture audio transcript.

---

1. Introduction to Bone 📚

Bone is a dynamic and vital tissue that performs numerous critical functions within the body. It provides structural integrity, protects internal organs, and is actively involved in metabolic processes.

2. Functions of Bone ✅

Bone serves several essential roles:

• Mechanical Support & Protection: Provides a rigid framework for the body and safeguards delicate visceral organs.
• Force Transmission: Acts as levers for muscles, transmitting forces generated by muscle contraction to facilitate movement.
• Mineral Homeostasis: Serves as a reservoir for essential minerals, primarily calcium and phosphorus, regulating their levels in the blood.
• Hematopoiesis: Produces blood cells (erythrocytes, lymphocytes, and platelets) within the bone marrow.
• Stem Cell Environment: Offers a crucial environment for both hematopoietic (blood-forming) and mesenchymal (connective tissue-forming) stem cells.

3. Bone Structure: Woven vs. Lamellar Bone 🔬

The bone matrix is synthesized in two primary histological forms, each with distinct characteristics:

3.1. Woven Bone

• Description: Immature bone, characterized by a haphazard arrangement of collagen fibers.
• Production Speed: Produced rapidly ⚡.
• Occurs During: Fetal development, fracture repair, and in bone-producing tumors.
• Structural Integrity: Less durable and structurally weaker due to irregular collagen fibers.
• Osteocytes: Contains more osteocytes compared to lamellar bone.
• Mineralization: Less mineralized.
• Clinical Significance: In adults, the presence of woven bone is always considered abnormal, although it is not specific to any particular bone disease.

3.2. Lamellar Bone

• Description: Mature bone, found in the adult skeleton (e.g., normal cortical and trabecular bone). Characterized by parallel collagen fibers arranged in layers (lamellae).
• Production Speed: Formed slowly 🐢.
• Structural Integrity: Durable and provides high structural integrity.
• Osteocytes: Contains fewer osteocytes (hypocellular) than woven bone.
• Mineralization: More mineralized.

4. Bone Homeostasis and Remodeling 🔄

The adult skeleton is constantly undergoing a tightly regulated process called remodeling, which involves continuous bone formation and resorption to maintain bone mass and repair micro-damage.

4.1. Key Signaling Pathways 📊

Several factors regulate this delicate balance:

• RANK/RANKL/OPG System:
  • RANK (Receptor Activator of NF-κB): A transmembrane receptor expressed on osteoclast precursors.
  • RANKL (RANK Ligand): Expressed on osteoblasts and marrow stromal cells; binds to RANK to activate osteoclast precursors.
  • OPG (Osteoprotegerin): A decoy receptor produced by osteoblasts that blocks RANKL from binding to RANK, thereby inhibiting osteoclast differentiation and activity.
• M-CSF (Monocyte-Colony Stimulating Factor): Produced by osteoblasts, it is essential for the differentiation of osteoclast precursors into functional osteoclasts.
• WNT Proteins: Produced by various cells, they bind to LRP5 and LRP6 receptors on osteoblasts, triggering OPG production and promoting bone formation.

4.2. Paracrine Mechanisms Regulating Osteoclasts 💡

• Osteoblast/stromal cell membrane-associated RANKL binds to RANK on osteoclast precursors.
• This interaction, along with M-CSF, causes precursor cells to differentiate into functional osteoclasts, leading to bone resorption.
• Stromal cells/osteoblasts also secrete OPG, which acts as a "decoy" receptor for RANKL, preventing it from binding to RANK.
• Consequently, OPG prevents bone resorption by inhibiting osteoclast differentiation.

5. Genetic and Metabolic Bone Disorders 🧬

5.1. Achondroplasia

• Definition: The most common form of dwarfism.
• Cause: Activating point mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. FGFR3 normally inhibits chondrocyte proliferation on the growth plate.
• Affected Bones: Impacts all bones that develop by enchondral ossification (e.g., long bones). The cartilage of the growth plates is disorganized and hypoplastic.
• Clinical Features: Shortened proximal extremities, relatively normal trunk length, enlarged head with bulging forehead (frontal bossing), and conspicuous depression of the root of the nose (midface hypoplasia). Bowing of the legs is also common.
• Inheritance: Autosomal dominant, but many cases arise from new spontaneous mutations.
• Prognosis: Usually not associated with changes in longevity, intelligence, or reproductive status.

5.2. Osteogenesis Imperfecta (OI) - "Brittle Bone Disease"

• Definition: A group of genetic disorders caused by defective synthesis of Type I collagen.
• Fundamental Abnormality: Too little bone, leading to extreme skeletal fragility.
• Extraskeletal Manifestations: Due to Type I collagen's presence in other tissues, symptoms can affect skin, joints, teeth, and eyes.
• Mutations: Involve coding sequences for α1 or α2 chains of Type I collagen, disrupting the entire collagen structure.
• Types:
  • Type I: Patients have a normal lifespan with a modestly increased tendency for fractures during childhood (decreasing after puberty).
  • Type II: Uniformly fatal in utero or immediately postpartum due to multiple fractures.
• Classic Findings:
  • Blue sclerae: Attributable to decreased scleral collagen content, allowing the underlying choroid to be seen.
  • Hearing loss: Related to conduction defects in the ear bones.
  • Small, misshapen teeth: Result of dentin deficiency.

5.3. Osteoporosis

• Definition: A metabolic bone disease characterized by progressive loss of bone mass, leading to increased risk of fractures.
• Primary Forms: Most common, associated with aging (senile osteoporosis) or postmenopausal state in women.
• Risk Factors:
  • Peak Bone Mass: Influenced by genetic, nutritional, and environmental factors earlier in life.
  • Age-related Changes: Reduced osteoblast proliferative and biosynthetic potential, leading to diminished capacity to make bone (low-turnover osteoporosis).
  • Reduced Physical Activity: Mechanical forces stimulate remodeling; decreased activity contributes to bone loss. Resistance exercises are more effective than endurance activities for increasing bone mass.
  • Genetic Factors: Single gene defects (e.g., LRP5 mutations in Wnt signaling pathway) account for a small fraction.
  • Calcium Nutritional State: Low dietary calcium intake (especially in adolescents) restricts peak bone mass. Deficiency, increased PTH, and reduced vitamin D also play a role.
  • Hormonal Influences: Estrogen deficiency after menopause significantly increases bone resorption (high-turnover osteoporosis). Decreased estrogen increases inflammatory cytokines (IL-6, TNF-α, IL-1) which stimulate osteoclast activity by increasing RANKL and diminishing OPG expression.
• Clinical Course:
  • Often asymptomatic until a fracture occurs (e.g., vertebral, hip).
  • Difficult to diagnose early; plain radiographs only detect after 30-40% bone mass loss.
  • Serum levels of calcium, phosphorus, and alkaline phosphatase are insensitive.
  • Diagnosis relies on specialized radiographic techniques like dual-energy X-ray absorptiometry (DEXA) and quantitative computed tomography.
  • Fractures can lead to complications like kyphoscoliosis (compromising respiratory function) and pulmonary embolism/pneumonia.

5.4. Hyperparathyroidism

• Definition: Excess production and activity of parathyroid hormone (PTH).
• Effect on Bone: Leads to increased osteoclastic activity, bone resorption, and osteopenia (reduced bone density).
• PTH's Role in Calcium Homeostasis:
  • Activates osteoclasts (via increased RANKL expression on osteoblasts), increasing bone resorption and mobilizing bone calcium.
  • Increases calcium reabsorption by renal tubules.
  • Increases urinary excretion of phosphates.
  • Increases synthesis of active vitamin D by kidneys, enhancing calcium absorption from the gut.
• Net Result: Elevated serum calcium.
• Types:
  • Primary: Autonomous parathyroid secretion (e.g., parathyroid adenoma).
  • Secondary: Occurs in the setting of underlying renal disease. Chronic renal insufficiency leads to inadequate vitamin D synthesis, causing decreased serum calcium and compensatory increased PTH (parathyroid hyperplasia). This can lead to bone deformation and joint problems.
• Prognosis: Bone changes can be reversed by reducing PTH levels to normal.

5.5. Paget Disease of Bone (Osteitis Deformans)

• Definition: A condition of increased, but disordered and structurally unsound bone.
• Phases:
  1. Osteolytic Stage: Initial phase with increased osteoclastic activity.
  2. Mixed Osteoclastic-Osteoblastic Stage: Both activities occur, with osteoblastic activity eventually predominating.
  3. Burned-Out Quiescent Osteosclerotic Stage: Final phase with dense, sclerotic bone.
• Epidemiology: Presents in mid to late adulthood. Common in Europe, Australia, New Zealand, and the US; rare in Scandinavia, China, Africa. Incidence is decreasing.
• Etiology: Both genetic and environmental factors.
  • Genetic: Mutations in the SQSTM1 gene (increasing NF-κB activity and osteoclastic activity). Activating mutations in RANK and inactivating mutations in OPG are seen in some juvenile cases.
  • Environmental: Geographic distribution suggests environmental influence; viral infections (e.g., measles) of osteoclast precursors have been implicated.
• Clinical Manifestations:
  • Involvement: Monostotic (15% - tibia, ilium, femur, skull, vertebrae, humerus) or polyostotic (85% - axial skeleton, proximal femur).
  • Lab Findings: Elevated serum alkaline phosphatase and increased urinary hydroxyproline reflect exuberant bone turnover.
  • Symptoms: Warmth of overlying skin (due to hypervascularity), headache, visual/auditory disturbances (skull involvement), back pain, nerve root compression (vertebral lesions).
  • Deformities: Affected long bones in legs often deformed; brittle long bones prone to "chalk stick" fractures.
  • Complications: High-output congestive heart failure (with extensive polyostotic disease due to hypervascularity). Sarcoma development (usually osteosarcoma) in ~1% of patients.
• Treatment: Usually follows a benign course; mild symptoms often controlled with bisphosphonates (interfere with bone resorption).

6. Bone Injury and Healing 🩹

6.1. Factors Disrupting Fracture Healing ⚠️

• Displaced and Comminuted Fractures: Result in deformity. Devitalized bone fragments require resorption, delaying healing, enlarging the callus, and potentially preventing complete normalization.
• Inadequate Immobilization: Constant movement at the fracture site prevents normal callus formation.
  • Healing site composed mainly of fibrous tissue and cartilage, leading to delayed union or non-union.
  • Excessive motion can cause cystic degeneration in the callus, forming a false joint called pseudoarthrosis.
• Infection: A serious obstacle, especially in comminuted and open fractures.
• Malnutrition and Systemic Conditions: Inadequate levels of calcium/phosphorus, vitamin deficiencies, systemic infection, diabetes, or vascular insufficiency impair bone repair.
• Age: Fractures in older individuals or abnormal bones (e.g., osteoporotic) often require orthopedic intervention for optimal repair.

7. Bone Infections (Osteomyelitis) 🦠

7.1. General Overview

• Definition: Inflammation of bone and marrow due to infection.
• Course: Can be acute or chronic.
• Common Agents: Pyogenic bacteria (most common) and Mycobacterium tuberculosis.

7.2. Pyogenic Osteomyelitis

• Causative Organisms:
  • Staphylococcus aureus: Most frequent cause.
  • Escherichia coli, Group B streptococci: Important in neonates.
  • Salmonella: Common in individuals with sickle cell disease.
  • Mixed bacterial infections (including anaerobes): Typically follow bone trauma.
  • No organism isolated in up to 50% of cases.
• Routes of Infection:
  1. Hematogenous Dissemination: Most common route.
  2. Extension from Adjacent Infection: From an infected joint or soft tissue.
  3. Traumatic Implantation: After compound fractures.
  4. Orthopedic Procedures.
• Morphology:
  • Bacterial proliferation induces acute inflammation and cell death.
  • Sequestrum: Entrapped central bone rapidly becomes necrotic.
  • Periosteum lifting impairs blood supply, leading to segmental bone necrosis.
  • Rupture of periosteum can lead to subperiosteal abscess formation and a draining sinus.
  • Epiphyseal infection can spread to adjoining joints, causing suppurative arthritis and potential permanent disability.
  • In vertebrae, infection can destroy intervertebral discs and spread.
  • After the first week, chronic inflammatory cells stimulate osteoclastic resorption, fibrous tissue ingrowth, and new bone formation.
  • Involucrum: Reactive woven or lamellar bone deposited around a sequestrum, forming a shell of living tissue. Viable organisms can persist in the sequestrum for years.

7.3. Tuberculous Osteomyelitis

• Etiology: Mycobacterial infection of bone, increasing due to new immigration patterns and immunocompromised populations.
• Prevalence: Occurs in 1-3% of pulmonary tuberculosis cases.
• Spread: Hematogenous dissemination.
• Favored Sites: Long bones and vertebrae.